Home
>
US Stocks
>
Guardant Health Inc
Guardant Health Inc
GH

Guardant Health Inc

$99.4415.61%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
101.13
Today Low/High
98.42 / 101.48
52 Week Low/High
$87.24 / $181.07
P/E ratio
-26.7688
Market Cap
$10.14B

Company Details

Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. The Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Guardant Health has commercially launched liquid biopsy-based Guardant360®, Guardant360 CDx, and GuardantOMNI® tests for advanced stage cancer patients, and Guardant Reveal™ for early-stage cancer patients. These tests fuel development of its LUNAR screening program, which aims to address the needs of asymptomatic individuals eligible for cancer screening and individuals at a higher risk for developing cancer with early detection.
Organisation
Guardant Health Inc
Employees
864
Industry
Health Services
Company Financials
  • Annual P&L
  • Quarterly P&L

Discover more

Frequently Asked Questions

What is Guardant Health Inc share price today

Can Indians buy Guardant Health Inc shares?

How can I buy Guardant Health Inc shares from India?

Can Fractional shares of Guardant Health Inc be purchased?

What are the documents required to start investing in Guardant Health Inc stocks?

We are a SEBI registered investement advisor